Results 111 to 120 of about 12,753,981 (303)
Molecular Oncology, EarlyView.We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Molecular Oncology, EarlyView.Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung +17 more
wiley +1 more source
The Correlation between Median Rhomboid Glossitis and Fungal Infection: A Review Article [PDF]
, 2020 Nanda Rachmad Putra Gofur
openalex +1 more source
Avi Rubin, Ottoman Nizamiye courts: law and modernity [PDF]
, 2012 This article is a book review on Avi Rubin's study, titled "Ottoman Nizamiye Courts.
Somel, Selcuk Aksin +1 more
core
Molecular Oncology, EarlyView.This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris +10 more
wiley +1 more source
Kan transkutan elektrisk nervestimulering lindre nevropatisk smerte?
Fysioterapeuten, 2006 In this article we have reviewed the research literature to find out if Transcutaneous Electrical Nerve Stimulation, known as TENS, can reduce pain and improve function for patients suffering from neuropathic pain. A literature search was made in medical
Anne Sofie Lofthus, Sara Maria Allen
doaj
Molecular Oncology, EarlyView.Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source